Naeve Gregory S. 4
4 · BELLICUM PHARMACEUTICALS, INC · Filed Jan 4, 2018
Insider Transaction Report
Form 4
Naeve Gregory S.
Sr. VP, Chief Business Officer
Transactions
- Award
Employee Stock Option (right to buy)
2018-01-02+14,625→ 14,625 totalExercise: $9.23Exp: 2028-01-01→ Common Stock (14,625 underlying) - Award
Restricted Stock Units
2018-01-02+8,125→ 8,125 total→ Common Stock (8,125 underlying)
Footnotes (3)
- [F1]25% of the shares subject to the stock option vest and become exercisable on January 2, 2019, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter.
- [F2]Each restricted stock unit represents a contingent right to receive one share of BLCM common stock.
- [F3]The restricted stock units vest in four equal annual installments beginning January 2, 2019.